Last week, Memphasys Associate Professor Hassan Bakos PhD MBA, our Director of Operations, paid a visit to our Felix™ device manufacturing partner, W&S Plastics to inspect the manufacturing site of the upcoming batch of Felix™ device cartridges.
This visit comes at an opportune moment as we prepare for anticipated orders resulting from recent commercial agreements with Vitrolife Pty. Ltd. New Zealand and Vitrolife Inc. Canada. These subsidiaries are part of the globally renowned IVF leader, Vitrolife AB.
The collaboration between Memphasys and Vitrolife is entering an exciting new phase, building upon the success of our exclusive distribution agreement for the Japanese market, which was established back in August 2023.
The upcoming batch of Felix™ device cartridges holds importance as it signifies our commitment to meeting the growing demands of our partners and customers. By ensuring the smooth manufacturing process, we aim to uphold the highest standards of quality and reliability in our products.
As we move forward, Memphasys remains dedicated to innovation, excellence, and customer satisfaction. We are excited about the opportunities that lie ahead and look forward to further enhancing our partnerships for the benefit of patients and healthcare providers globally.